FDA panel backs vaccine
An advisory panel at the US Food and Drug Administration recommended approval of an eagerly awaited vaccine for Lyme disease, a potentially fatal illness afflicting about 15,000 Americans each year,
An advisory panel at the US Food and Drug Administration recommended approval of an eagerly awaited vaccine for Lyme disease, a potentially fatal illness afflicting about 15,000 Americans each year,